Skip to content
Parakho

Sudeep Pharma Ltd

NSE SUDEEPPHRMBSE 544619sudeepgroup.com

Q1 FY27, unaudited

Revenue
₹158.27 Cr
Profit after tax
₹40.59 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations158.27—642.26
Other income5.45—28.59
Total income163.72—670.84
Employee benefit expense14.34—51.89
Finance costs2.06—7.60
Depreciation & amortisation4.00—14.81
Total expenses109.42—442.77
Profit before tax54.29—228.07
Tax expense13.71—53.79
Profit after tax40.59—174.28
Total comprehensive income40.53—173.06
Earnings per share
Earnings per share, basic₹3.59₹15.50
Earnings per share, diluted₹3.59₹15.50

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Why the dash

Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.

Earnings call

Q1 FY27

Sudeep Pharma reported Q1 FY27 revenue growth of 27% year-on-year to Rs 158.3 crores, with EBITDA up 25% to Rs 54.9 crores and profit after tax rising to Rs 40.6 crores. Growth was driven by the pharma, food and nutrition segment which grew 31%, while specialty ingredients grew 19%, partly held back by an LPG supply shortage in April and early May. Management also discussed progress at the Sudeep Advanced Materials battery-chemicals project, the performance of the NSS European subsidiary, and a phosphoric acid price increase during the quarter.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 41 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Commodities › Chemicals › Specialty Chemicals

Classification as published by BSE.

Companies also in Specialty Chemicals, in alphabetical order

All 112 companies in Specialty Chemicals

Page generated from filings held to 07 Oct 2026.